Shah HS, Moreno LO, Morieri ML, Tang Y, et al. Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies. Diabetes Care 2022;45:1882-1892.
PMID: 35696261